Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-16

Clinical Trial Update: Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of pomegranate supplementation on physical function and cardiovascular disease risk in patients with chronic ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomegranate supplement (pomegranate extract supplement)

Snippet

Sponsor: Kenneth Wilund | Conditions: Chronic Kidney Disease, Cardiovascular Disease | NA | Status: COMPLETED